Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 2
2013 2
2014 3
2015 8
2016 4
2017 10
2018 18
2019 18
2020 41
2021 42
2022 48
2023 33
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean xiaoyang mo (42 results)?
Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion.
Tao C, Nogueira RG, Zhu Y, Sun J, Han H, Yuan G, Wen C, Zhou P, Chen W, Zeng G, Li Y, Ma Z, Yu C, Su J, Zhou Z, Chen Z, Liao G, Sun Y, Ren Y, Zhang H, Chen J, Yue X, Xiao G, Wang L, Liu R, Liu W, Liu Y, Wang L, Zhang C, Liu T, Song J, Li R, Xu P, Yin Y, Wang G, Baxter B, Qureshi AI, Liu X, Hu W; ATTENTION Investigators. Tao C, et al. N Engl J Med. 2022 Oct 13;387(15):1361-1372. doi: 10.1056/NEJMoa2206317. N Engl J Med. 2022. PMID: 36239644 Clinical Trial.
Safety outcomes included symptomatic intracranial hemorrhage at 24 to 72 hours, 90-day mortality, and procedural complications. RESULTS: Of the 507 patients who underwent screening, 340 were in the intention-to-treat population, with 226 assigned to the thrombectomy group …
Safety outcomes included symptomatic intracranial hemorrhage at 24 to 72 hours, 90-day mortality, and procedural complications. RESUL …
Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial.
Zi W, Qiu Z, Li F, Sang H, Wu D, Luo W, Liu S, Yuan J, Song J, Shi Z, Huang W, Zhang M, Liu W, Guo Z, Qiu T, Shi Q, Zhou P, Wang L, Fu X, Liu S, Yang S, Zhang S, Zhou Z, Huang X, Wang Y, Luo J, Bai Y, Zhang M, Wu Y, Zeng G, Wan Y, Wen C, Wen H, Ling W, Chen Z, Peng M, Ai Z, Guo F, Li H, Guo J, Guan H, Wang Z, Liu Y, Pu J, Wang Z, Liu H, Chen L, Huang J, Yang G, Gong Z, Shuai J, Nogueira RG, Yang Q; DEVT Trial Investigators. Zi W, et al. JAMA. 2021 Jan 19;325(3):234-243. doi: 10.1001/jama.2020.23523. JAMA. 2021. PMID: 33464335 Free PMC article. Clinical Trial.
Safety outcomes included the incidence of symptomatic intracerebral hemorrhage within 48 hours and 90-day mortality. RESULTS: The trial was stopped early because of efficacy when 234 of a planned 970 patients had undergone randomization. ...No significant between-group dif …
Safety outcomes included the incidence of symptomatic intracerebral hemorrhage within 48 hours and 90-day mortality. RESULTS: The tri …
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.
Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, Lei F, Wang H, Xie J, Wang W, Li H, Zhang P, Song X, Chen X, Xiang M, Zhang C, Bai L, Xiang D, Chen MM, Liu Y, Yan Y, Liu M, Mao W, Zou J, Liu L, Chen G, Luo P, Xiao B, Zhang C, Zhang Z, Lu Z, Wang J, Lu H, Xia X, Wang D, Liao X, Peng G, Ye P, Yang J, Yuan Y, Huang X, Guo J, Zhang BH, Li H. Zhu L, et al. Cell Metab. 2020 Jun 2;31(6):1068-1077.e3. doi: 10.1016/j.cmet.2020.04.021. Epub 2020 May 1. Cell Metab. 2020. PMID: 32369736 Free PMC article.
We found that subjects with T2D required more medical interventions and had a significantly higher mortality (7.8% versus 2.7%; adjusted hazard ratio [HR], 1.49) and multiple organ injury than the non-diabetic individuals. Further, we found that well-controlled BG (glycemi …
We found that subjects with T2D required more medical interventions and had a significantly higher mortality (7.8% versus 2.7%; adjus …
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Yang X, et al. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Lancet Respir Med. 2020. PMID: 32105632 Free PMC article.
Data were compared between survivors and non-survivors. The primary outcome was 28-day mortality, as of Feb 9, 2020. Secondary outcomes included incidence of SARS-CoV-2-related acute respiratory distress syndrome (ARDS) and the proportion of patients requiring mechanical v …
Data were compared between survivors and non-survivors. The primary outcome was 28-day mortality, as of Feb 9, 2020. Secondary outcom …
Deep learning-enabled pelvic ultrasound images for accurate diagnosis of ovarian cancer in China: a retrospective, multicentre, diagnostic study.
Gao Y, Zeng S, Xu X, Li H, Yao S, Song K, Li X, Chen L, Tang J, Xing H, Yu Z, Zhang Q, Zeng S, Yi C, Xie H, Xiong X, Cai G, Wang Z, Wu Y, Chi J, Jiao X, Qin Y, Mao X, Chen Y, Jin X, Mo Q, Chen P, Huang Y, Shi Y, Wang J, Zhou Y, Ding S, Zhu S, Liu X, Dong X, Cheng L, Zhu L, Cheng H, Cha L, Hao Y, Jin C, Zhang L, Zhou P, Sun M, Xu Q, Chen K, Gao Z, Zhang X, Ma Y, Liu Y, Xiao L, Xu L, Peng L, Hao Z, Yang M, Wang Y, Ou H, Jia Y, Tian L, Zhang W, Jin P, Tian X, Huang L, Wang Z, Liu J, Fang T, Yan D, Cao H, Ma J, Li X, Zheng X, Lou H, Song C, Li R, Wang S, Li W, Zheng X, Chen J, Li G, Chen R, Xu C, Yu R, Wang J, Xu S, Kong B, Xie X, Ma D, Gao Q. Gao Y, et al. Lancet Digit Health. 2022 Mar;4(3):e179-e187. doi: 10.1016/S2589-7500(21)00278-8. Lancet Digit Health. 2022. PMID: 35216752 Free article.
Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.
Qin T, Li B, Feng X, Fan S, Liu L, Liu D, Mao J, Lu Y, Yang J, Yu X, Zhang Q, Zhang J, Song B, Li M, Li L. Qin T, et al. J Exp Clin Cancer Res. 2018 Nov 27;37(1):287. doi: 10.1186/s13046-018-0934-9. J Exp Clin Cancer Res. 2018. PMID: 30482232 Free PMC article.
RESULTS: Bioinformatics analysis demonstrated that USP37 gene was elevated in breast cancer tissues and its overexpression was strongly correlated with the increased mortality rate. GSEA analysis showed that USP37 expression was positively associated with cell growth and m …
RESULTS: Bioinformatics analysis demonstrated that USP37 gene was elevated in breast cancer tissues and its overexpression was strongly corr …
RIG-I promotes immune evasion of colon cancer by modulating PD-L1 ubiquitination.
Zhang Y, Zeng L, Wang M, Yang Z, Zhang H, Gao L, Zhang R, Liu J, Shan W, Chang Y, Liu L, Zhao Q, Li Y, Liu J. Zhang Y, et al. J Immunother Cancer. 2023 Sep;11(9):e007313. doi: 10.1136/jitc-2023-007313. J Immunother Cancer. 2023. PMID: 37758653 Free PMC article.
Colon cancer is one of the most prevalent cancers and exhibits high mortality worldwide. Despite the certain success in the immunotherapy of many tumor types, the limited response of colon cancer to immunotherapy remains a difficult problem. ...
Colon cancer is one of the most prevalent cancers and exhibits high mortality worldwide. Despite the certain success in the immunothe …
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.
Jiang Z, Ouyang Q, Sun T, Zhang Q, Teng Y, Cui J, Wang H, Yin Y, Wang X, Zhou X, Wang Y, Sun G, Wang J, Zhang L, Yang J, Qian J, Yan M, Liu X, Yi T, Cheng Y, Li M, Zang A, Wang S, Wang C, Wu X, Cheng J, Li H, Lin Y, Geng C, Gu K, Xie C, Xiong H, Wu X, Yang J, Li Q, Chen Y, Li F, Zhang A, Zhang Y, Wu Y, Nie J, Liu Q, Wang K, Mo X, Chen L, Pan Y, Fu P, Zhang H, Pang D, Sheng Y, Han Y, Wang H, Cang S, Luo X, Yu W, Deng R, Yang C, Keegan P. Jiang Z, et al. Nat Med. 2024 Jan;30(1):249-256. doi: 10.1038/s41591-023-02677-x. Epub 2024 Jan 8. Nat Med. 2024. PMID: 38191615 Clinical Trial.
Leukapheresis and Hyperleukocytosis, Past and Future.
Zhang D, Zhu Y, Jin Y, Kaweme NM, Dong Y. Zhang D, et al. Int J Gen Med. 2021 Jul 14;14:3457-3467. doi: 10.2147/IJGM.S321787. eCollection 2021. Int J Gen Med. 2021. PMID: 34285568 Free PMC article. Review.
Hyperleukocytosis is a hematologic crisis caused by excessive proliferation of leukemic cells and has a relatively high early mortality due to a series of severe complications. Therefore, prompt and effective intervention is required. ...
Hyperleukocytosis is a hematologic crisis caused by excessive proliferation of leukemic cells and has a relatively high early mortality …
210 results